Anthem-Cigna Deal Will Still Happen, Leerink Says
CIGNA Corporation (NYSE: CI) is likely to accept a bid of $190 a share from Anthem Inc (NYSE: ANTM) an analyst said Tuesday.
Cigna, which rejected a $184 a share cash-and-stock bid from Anthem on Sunday, traded recently at $164.75, up $1.35.
Leerink's Ana Gupta said the deal between the two insurance giants "will come to fruition" although Anthem may boost its latest bid by about 3 percent.
Gupta also said Humana Inc (NYSE: HUM) is unlikely to serve as a "second choice" for Anthem.
Aetna Inc (NYSE: AET) made a recent offer for Humana, according to a report last week by The Wall Street Journal which the companies haven't confirmed.
Aetna "looks like the only viable dance partner" for Humana, according to Gupte, who said Humana will fetch at least $210 a share.
Humana traded recently at $189.86, down $0.04.
Cigna, in rejecting Anthem's bid Sunday, raised anti-trust and governance concerns, which Gupte said are "addressable."
Cigna's Chief Executive David Cordani apparently doesn't want to get left out after a deal, and Gupte said a "co-chairman" role will probably be offered.
If Anthem sweetens its offer for Cinga, it would be the fifth in a string of offers for Cigna that Anthem has made, starting with a bid of $174 a share on June 3, according to a letter disclosed Sunday.
Latest Ratings for CI
Jun 2015 | RBC Capital | Initiates Coverage on | Sector Perform | |
Jun 2015 | Leerink Swann | Reiterates | Outperform | |
Jun 2015 | Leerink Swann | Reiterates | Outperform |
View More Analyst Ratings for CI
View the Latest Analyst Ratings
See more from Benzinga
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
